Establishment Labs Holdings Inc Mia Day Transcript
Before we begin, I just want to put up our agenda for today. We're going to have a session today on Mia, as everybody knows about talking about a new concept in aesthetics. So I'll have a couple of minutes here at the open, and then I'll turn it over to Juan Jose to talk about Mia in some detail. We'll have a video narrated by Dr. Marcus Sforza and Dr. Charles Randquist. Rosalyn d'Incelli will provide an update on clinical and regulatory status for Mia. And then I'll close with some information on the market potential and commercial model we have for Mia. And then we'll also have some Q&A for people that are here in the room.
Before we begin, of course, we have the safe harbor and forward-looking statements, slide, the ubiquitous slide. And we also have some additional disclosures. As everybody knows, Mia is not available for sale yet and we are undergoing an FDA study in the United States as well for our Motiva implants. I'd also point out that there are some comments made by Dr. Marcos Sforza and Dr. Charles Randquist during the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |